Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 24-30, 2000;
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, C.-C.
Right arrow Articles by Waters, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, C.-C.
Right arrow Articles by Waters, D. J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:24-30.)
© 2000 American Association for Clinical Chemistry, Inc.


Articles

5' Nuclease Assays for the Loci CCR5-+/{Delta}32, CCR2-V64I, and SDF1-G801A Related to Pathogenesis of AIDS

Chiu-Chin Yuan, Raymond J. Peterson1,1, Cheng-Dian Wang, Frederico Goodsaid2 and David J. Watersa

1 Laboratory of Genomic Diversity, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702.

2 PE Applied Biosystems, 850 Lincoln Centre Dr., Foster City, CA 94404.
a Author for correspondence. Fax 301-846-6468; e-mail waters{at}avpaxp1.ncifcrf.gov


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: Variations within the human genome play important roles in human disease. To study variations related to susceptibility to AIDS, we have developed 5' nuclease assays that eliminate post-PCR molecular biology steps.

Methods: TaqMan assays based on the 5' nuclease activity of Taq polymerase and fluorescent resonance energy transfer were developed to score alleles at the biallelic loci CCR5-+/{Delta}32, CCR2-V64I and SDF1-G801A. For each assay, 72 samples were analyzed. Data collection and analysis were performed on the Prism 7700 Sequence Detection System. For comparison with gel electrophoresis methods, each locus was also scored on a subset of 24 samples, using restriction enzymes or single-strand conformational polymorphism (SSCP).

Results: Clear allelic discrimination was obtained on each of the 72 samples for all three TaqMan assays. The TaqMan scores for the subset of 24 samples were concordant with the restriction enzyme and SSCP scores.

Conclusions: Because of its simplicity, speed, and potential for automation and miniaturization, TaqMan is an excellent candidate for investigation of genetic variation in clinical, research, and forensic settings.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Nucleotide substitutions and short-length differences of unique sequence play an important role in both simple and complex genetic disorders (1) and drug response (2). Across the human genome, ~1 in every 1000 bp is varied between any two chromosomes (3)(4). These latter variants, known as single nucleotide polymorphisms (SNPs),2 may be ideal for mapping disease genes using association and linkage disequilibrium (5). In addition, SNPs may also play a role in human identity (6). For these applications, there is much interest in the development of nucleic acid assays for molecular diagnosis (7).

Three alleles that protect against AIDS and that can be used for large-scale population studies are CCR5-{Delta}32 (8), CCR2-64I (9), and SDF1-801A (10). HIV-1, the virus that causes AIDS, uses the chemokine receptors CCR5 and CCR2 as coreceptors with CD4 for entry into lymphoid cells. The CCR5-{Delta}32 allele is a 32-bp deletion that truncates the CCR5 protein (8). The truncated protein fails to reach the cell surface, leading to reduced density of CCR5 receptors. This receptor loss slows HIV-1 cell entry and delays AIDS progression (8). For CCR2-V64I, a G-to-A substitution in the coding region causes valine to be replaced by isoleucine (9). People who carry isoleucine, or a completely linked allele, have delayed progression of AIDS (11). Stromal-derived factor (SDF1, also known as pre-B-cell growth-stimulating factor) is the natural ligand for the chemokine receptor CXCR4. A G-to-A substitution in the 3' untranslated region has a recessive protective effect in HIV-1-infected patients for extended periods of exposure (10).

Worldwide population surveys indicate that CCR5-{Delta}32, CCR2-64I, and SDF1-801A attain frequencies of >=15% in some populations (9)(10)(12). Recently, it has been reported that CCR5-{Delta}32 and SDF1-A protect against AIDS-related non-Hodgkin lymphoma (13). These worldwide frequencies and disease results suggest that CCR5-{Delta}32, CCR2-64I, and SDF1-801A are good candidates for protection against additional infectious agents, AIDS-related cancers, and non-AIDS-related cancers.

Several methods are available for scoring SNPs (14). These include restriction endonucleases (15), single-strand conformational polymorphism (SSCP) (16), heteroduplex analysis (17), sequencing by hybridization chips (18), primer extension (19), and direct sequencing (20). All of these methods require molecular biology steps after PCR, and most require gel or capillary electrophoresis. Such steps can be complex, time-consuming, expensive, and labor-intensive. Two additional methods, molecular beacons (21)(22)(23) and the 5' nuclease assay (24)(25), have an advantage in that allelic discrimination occurs during PCR. This eliminates post-PCR molecular biology steps and the need for electrophoresis. Molecular beacons currently require fluorescent detection of assay plates during PCR, thus limiting throughput to one plate per unit of PCR thermal cycling time on a dedicated real-time PCR instrument. For this study, the 5' nuclease assay, or TaqMan, was chosen because assay plates can be processed in parallel on a battery of thermal cyclers and transferred to a fluorescent plate reader for analysis.

Each TaqMan assay requires two fluorogenic allele-specific probes (24)(26). One probe matches the wild-type sequence, and one probe matches the mutant sequence. Each probe is labeled at the 5' end with a fluorescent reporter dye and at the 3' end with the quencher dye 6-carboxytetramethylrhodamine (TAMRA). The reporter dyes used in this study were 6-carboxyfluorescein (FAM) for the wild-type sequence and VIC for the mutant sequence. In the PE Biosystems TaqMan platform, the reporter dye VIC recently replaced the reporter dyes JOE (2,7-dimethoxy-4,5-dichloro-6-carboxyfluorescein) and HEX (hexachloro-6-carboxyfluorescein) because VIC has an intensity more equal to that of FAM and because its narrower spectrum has less overlap with FAM. Both qualities improve signal processing and thus allelic discrimination (27). In solution, the proximity of the dyes on each probe allows TAMRA to absorb energy from the reporter dye through fluorescent resonance energy transfer (Fig. 1 ) (26). During PCR amplification, reporter signal is increased when hybridized probes are cleaved by the 5' nuclease activity of the Taq polymerase. Mismatches between a probe and its target sequence reduce probe hybridization efficiency and subsequent cleavage. An allele is detected as significantly increased intensity of its reporter dye over background. The fluorescent dye 6-carboxy-X-rhodamine (ROX) is included in each assay to normalize variation in signal strength among wells.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Schematic of TaqMan principle polymerization catalyzed by the Taq enzyme proceeds as typical for a PCR reaction using forward and reverse primers.

Allele-specific fluorogenic probes, 5' labeled with a reporter dye and 3' labeled with a quencher dye, hybridize to complementary templates. Proximity of the two dyes allows the quencher dye to absorb the emission of the reporter dye. During polymerization, the Taq enzyme displaces and cleaves hybridized probes, producing an exponential increase in cleaved reporter dye emission.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
dna samples
The DNA samples used here were collected for ongoing studies of AIDS and AIDS-related cancers.

primers and probes
Primers (Operon Technologies.) and probes (PE Biosystems; Table 1 ) were designed using the Primer Express computer-aided primer design software (PE Biosystems) following the manufacture’s published guidelines. Briefly, the polymorphic site lies in the middle one-third of the probes. Probe lengths were adjusted such that both probes had approximately the same melting temperature (67.0 °C) (24)(25). The probe melting temperature was 7.0–8.0 °C above the primer melting temperatures of 59.0–60.0 °C as determined by the nearest neighbor algorithm implemented in Primer Express. For CCR5-+/{Delta}32, the wild-type probe is the 32 bp that are deleted in the mutant allele. The mutant allele probe spans the junction of the deleted sequence.


View this table:
[in this window]
[in a new window]
 
Table 1. Oligonucleotide probe and primer sequences.1

pcr conditions
TaqMan Universal Master Mix (PE Biosystems) was used at a final concentration of 1x and volume of 25 µL along with 50–100 ng of genomic DNA. Probe concentrations were initially optimized for each assay to yield equal relative fluorescence. However, it was found that excellent allelic discrimination was obtained for all assays when 200 nmol/L final probe concentration and 900 nmol/L final primer concentration were used. The thermal cycling profile was that recommended by the manufacturer: 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 62 ° C for 1 min. Optical plates (PE Biosystems) were thermal cycled in the Prism 7700 Sequence Detection System (SDS) for real-time detection for Fig. 2 , A–D. Otherwise, plates were thermal cycled on GeneAmp PCR System 9700 (PE Biosystems) and analyzed on the 7700 using end-point analysis.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. CCR2-V64I fluorescent signals.

(A–D), pure dye contributions for sample with reagents but no template DNA (A), a G/G FAM homozygote (B), a A/A VIC homozygote (C), and a G/A FAM/VIC heterozygote (D). Bkgnd, background. Panel E contrasts the normalized allelic signal from each probe based on the pure dye contributions. No Amp, no amplification. See text for details.

other tests
Restriction enzyme digests, SSCP, and subsequent electrophoresis were performed following standard procedures.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
raw fluorescent spectra
In the TaqMan assay, the presence of four dyes in each sample well produces a composite fluorescent spectrum. For each biallelic locus, there are three possible emission patterns: homozygous wild type, heterozygous, and homozygous mutant. A fourth pattern is also observed when control samples are included on the assay plate that have reagents but no template DNA (no-template control). To capture the composite fluorescent spectra, the 7700 excites the dyes using a 488 nm laser and collects emission intensity at 32 discrete wavelengths between 500 and 650 nm. This range encompasses the peak emission wavelengths of FAM (535 nm), VIC (550 nm), TAMRA (580 nm), and ROX (605 nm).

dye contributions
The composite spectra are then processed to estimate the contribution of each dye. Estimation is accomplished by the SDS software, using a multicomponent linear model based on the spectrum of each pure dye. For the CCR2-V64I assay, the estimated contributions of individual dyes to the four possible emission patterns are illustrated in Fig. 2Up , A–D. Readings were taken during the course of a real-time PCR experiment. Fig. 2AUp depicts the no-template control. As can be seen, there was little change in fluorescent intensity of either reporter dye after thermal cycling. In contrast, Fig. 2BUp illustrates a 2.5-fold increase in FAM and a 1.1-fold increase in VIC for a G/G homozygote. The slight increase in VIC is attributable to nonspecific hybridization. Similarly, Fig. 2CUp depicts a 2.1-fold increase in VIC and a 1.4-fold increase in FAM for an A/A homozygote. Lastly, Fig. 2DUp shows a 2.0-fold increase in FAM and a 1.8-fold increase in VIC for a G/A heterozygote. In Fig. 2Up , B–D, the quencher TAMRA decreases because of probe cleavage and disassociation of reporter and quencher dyes. In Fig. 2Up , A–D, the intensity of ROX remains unchanged.

allelic contributions
To infer genotype, the allelic contribution to each sample is estimated in the SDS software by substituting homozygote fluorescent spectra for the pure dye spectra in the multicomponent linear model. For this reason, eight replicate samples inferred to be homozygous for each allele must be included on each assay plate and designated as Allele 1 and Allele 2 controls in the SDS software. In this study, FAM was designated as Allele 1 and VIC was designated as Allele 2. The SDS software makes an additional normalization for background to an approximate 0.0–1.0 scale by inclusion of eight replicate samples for which reagents but no template DNA is added. These replicates are designated as No Template Controls. In total, control samples occupy 24 wells of the 96-well plate. Samples for which genotype were to be determined are designated in the SDS software as Unknowns.

For the CCR2-V64I assay, Fig. 2EUp contrasts the normalized allele G (FAM) and allele A (VIC) contributions for 72 samples and 24 controls. This plot clearly reveals four distinct clusters. These clusters are further defined visually by genotype-specific colors. Similar results were obtained for the SDF1-G801A and CCR5-+/{Delta}32 assays, using a single set of reagent concentrations and thermal cycling conditions. The scatter plot patterns of individual samples were highly reproducible across repeated experiments performed on different days by different people using PCR reagents freshly aliquoted from individual stock vials.

Allelic contributions normalized to background for 22 samples for the CCR2-V64I assay are listed in Table 2 . The first seven samples were estimated to have no contribution from either Allele 1 or Allele 2 and thus were inferred by the software to have failed PCR amplification (No Amp). The next seven samples were estimated to have intermediate contributions of both alleles and were assigned heterozygous status. The next sample had a low estimated Allele 1 contribution and a high Allele 2 contribution. Because of this, it was inferred by the software to have only an Allele 2 contribution and thus to be an A/A homozygote. The remaining seven samples listed in Table 1Up had a high estimated Allele 1 contribution and a low estimated Allele 2 contribution. These samples were inferred by the software as to match the Allele 1 control and thus to be G/G homozygotes.


View this table:
[in this window]
[in a new window]
 
Table 2. CCR2-V64I normalized allelic contribution and AutoCall.

comparison with restriction enzyme and sscp assays
SDF1-G801A is a MspI restriction site polymorphism, which allows PCR-restriction enzyme analysis. Fig. 3 aligns the SDS genotype call (Fig. 3A ) with the 3% agarose gel electrophoretic pattern (Fig. 3B ) for 24 samples that were subjected to both TaqMan and MspI restriction enzyme analysis. In all cases, the SDS call was concordant with the genotype inferred from the electrophoretic band pattern. The electrophoretic band patterns of the genotype controls match those predicted from electronic digestion of allele-specific 302-bp reference amplicons. Genotype calls were also concordant for CCR5-+/{Delta}32, for which the 32-bp deletion was resolved simply by length differences of PCR products on a 6% polyacrylamide gel, and for the SSCP pattern of CCR2-V64I.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 3. SDF1-G801A TaqMan assay vs MspI assay.

Comparison of the 5' nuclease SDS genotype call to PCR-MspI restriction enzyme electrophoretic pattern for 24 samples. (A), SDS genotype call; (B), MspI digest electrophoretic pattern. Lane 1, G/G homozygote; lane 2, A/A homozygote; lane 3, G/A heterozygote. •, A/A (2/2) homozygote; {diamondsuit}, G/G (1/1) homozygote; {blacksquare}, G/A (1/2) heterozygote.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
TaqMan allelic discrimination assays were developed and validated to score the AIDS protection alleles CCR5-{Delta}32, CCR2-64I, and SDF1-801A. Whereas the CCR5-+/{Delta}32 locus comprised alleles of different lengths, CCR2-V64I and SDF1-G801A were examples of SNPs. Thus, the CCR2-V64I and SDF1-G801A assays increase the number of SNPs for which a successful TaqMan assay has been reported.

A major consideration for large-scale SNP scoring is the frequency with which a designed assay actually yields acceptable discrimination. This is particularly relevant to TaqMan assays because, whereas the probe cost per sample is low when a large number of samples are scored, the synthesis of dually labeled probes remains expensive. During development of the three assays presented here, the first set of CCR5-+/{Delta}32 and CCR2-V64I primers and probes designed with the aid of Primer Express yielded excellent discrimination. Although the first combination of SDF1-G801A primers and probes gave poor discrimination, a second primer set lying completely outside the original pair yielded excellent discrimination. These results suggest that probe hybridization technology is advancing to the point of enabling routine design of TaqMan assays.

Compared with restriction enzymes, SSCP, and gel electrophoresis, TaqMan allelic discrimination is much faster and easier. Primer Express simplifies complicated assay design, and the elimination of post-PCR molecular biology steps reduces labor and supply costs as well as the risk of contamination by PCR product. Use of a single set of reagent concentrations and thermal cycling conditions eases logistics at the bench. Genotype calls are electronically captured, thereby eliminating human error associated with manual recording of gel electrophoretic data. Because several thermal cyclers can be used in parallel and plates can be read on the Prism 7700 using SDS software in end-point mode, hundreds of samples can be processed daily by a single technician.

As indicated earlier in the text, several methods are available for SNP scoring (14). Each method has advantages and disadvantages. Some, like sequencing by hybridization chips, are currently more amenable to scoring many SNPs on a few people (18). Others, like TaqMan, currently are amenable to scoring a few SNPs on many people. Because of this, no one SNP scoring method is likely to have universal appeal. However, only a few methods are likely to have widespread use. The methods that dominate will do so based on cost and ease of use.

Interestingly, there are two organizational strategies for performing TaqMan assays on a microtiter plate. Here, we processed many DNA samples for a single SNP. The reverse strategy is to process a single DNA sample for many SNPs. This latter strategy is commercially available only for TaqMan gene expression studies. As density increases from 96 to 384 and on to 1536 wells, this strategy converges on the chip strategy (18).

One application of TaqMan technology is forensics. A recent report indicated that only 50 SNPs, each with a minor allele frequency of 0.20, are needed to equal the statistical power of the current forensic standard of 13 short-tandem repeat loci (6). This number of SNPs can be accommodated in the current 96-well format.

With respect to cost, the nature of the TaqMan assay eliminates much of the labor involved with SNP scoring. Because TaqMan requires only PCR and fluorescent detection, it has great potential for automation (26). Reagent costs can be reduced by reducing reaction volume, and a miniature TaqMan system has been reported (28). Although the practical limit of commercially available technology is currently in the 5-µL range, microfluidic devices may soon reduce practical volumes to 1 µL or less. Together, these advantages suggest that TaqMan SNP assays may be a generally useful SNP scoring strategy for clinical diagnostics, research, and forensics.


   Acknowledgments
 
This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. N01-CO-56000. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organization imply endorsement by the US Government.


   Footnotes
 
1AIDS Vaccine Program, SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702.

1 Current address: Silicon Genomics, Greenbelt, MD 20770.

2 Nonstandard abbreviations: SNP, single nucleotide polymorphism; SDF, stroma-derived factor; SSCP, single-strand conformational polymorphism; TAMRA, 6-carboxytetramethylrhodamine; FAM, 6-carboxyfluorescein; ROX, 6-carboxy-X-rhodamine; and SDS, Sequence Detection System.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247. [ISI][Medline] [Order article via Infotrieve]
  2. Housman D, Ledley FD. Why pharmacogenomics? Why now?. Nat Biotechnol 1998;16:492-493. [ISI][Medline] [Order article via Infotrieve]
  3. Cooper DN, Smith BA, Cooke HJ, Niemann S, Schmidtke J. An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 1985;69:201-205. [ISI][Medline] [Order article via Infotrieve]
  4. Kwok PY, Deng Q, Zakeri H, Taylor SL, Nickerson DA. Increasing the information content of STS-based genome maps: identifying polymorphisms in mapped STSs. Genomics 1996;31:123-126. [ISI][Medline] [Order article via Infotrieve]
  5. Chakravarti A. Population genetics–making sense out of sequence. Nat Genet 1999;21:56-60. [ISI][Medline] [Order article via Infotrieve]
  6. Chakraborty R, Stivers DN, Su B, Zhong Y, Budowle B. The utility of short tandem repeat loci beyond human identification: implications for development of new DNA typing systems. Electrophoresis 1999;20:1682-1696. [ISI][Medline] [Order article via Infotrieve]
  7. Kricka LJ. Nucleic acid detection technologies–labels, strategies, and formats. Clin Chem 1999;45:453-458. [Abstract/Free Full Text]
  8. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862. [Abstract/Free Full Text]
  9. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-965. [Abstract/Free Full Text]
  10. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393. [Abstract/Free Full Text]
  11. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998;4:350-353. [ISI][Medline] [Order article via Infotrieve]
  12. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, et al. Dating the origin of the CCR5-{Delta}32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 1998;62:1507-1515. [ISI][Medline] [Order article via Infotrieve]
  13. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin’s lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999;93:1838-1842. [Abstract/Free Full Text]
  14. Landegren U, Nilsson M, Kwok PY. Reading bits of genetic information: methods for single-nucleotide polymorphism analysis. Genome Res 1998;8:769-776. [Free Full Text]
  15. Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human ß-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A 1978;75:5631-5635. [Abstract/Free Full Text]
  16. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989;86:2766-2770. [Abstract/Free Full Text]
  17. Dean M. Resolving DNA mutations [News]. Nat Genet 1995;9:103-104. [ISI][Medline] [Order article via Infotrieve]
  18. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, et al. Accessing genetic information with high-density DNA arrays. Science 1996;274:610-614. [Abstract/Free Full Text]
  19. Pastinen T, Partanen J, Syvanen AC. Multiplex, fluorescent, solid-phase minisequencing for efficient screening of DNA sequence variation. Clin Chem 1996;42:1391-1397. [Abstract/Free Full Text]
  20. Cotton RG. Current methods of mutation detection. Mutat Res 1993;285:125-144. [ISI][Medline] [Order article via Infotrieve]
  21. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996;14:303-308. [ISI][Medline] [Order article via Infotrieve]
  22. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998;16:49-53. [ISI][Medline] [Order article via Infotrieve]
  23. Kostrikis LG, Tyagi S, Mhlanga MM, Ho DD, Kramer FR. Spectral genotyping of human alleles. Science 1998;279:1228-1229. [Free Full Text]
  24. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999;14:143-149. [Medline] [Order article via Infotrieve]
  25. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 1995;4:357-362. [ISI][Medline] [Order article via Infotrieve]
  26. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening [Letter]. Nat Genet 1995;9:341-342. [ISI][Medline] [Order article via Infotrieve]
  27. PE Applied Biosystems. Multiplex PCR with TaqMan VIC Probes. User Bulletin No. 5. Foster City, CA: PE Applied Biosystems, 1998..
  28. Ibrahim MS, Lofts RS, Jahrling PB, Henchal EA, Weedn VW, Northrup MA, et al. Real-time microchip PCR for detecting single-base differences in viral and human DNA. Anal Chem 1998;70:2013-2017. [Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
J. Immunol.Home page
S.-C. Chen, G. Vassileva, D. Kinsley, S. Holzmann, D. Manfra, M. T. Wiekowski, N. Romani, and S. A. Lira
Ectopic Expression of the Murine Chemokines CCL21a and CCL21b Induces the Formation of Lymph Node-Like Structures in Pancreas, But Not Skin, of Transgenic Mice
J. Immunol., February 1, 2002; 168(3): 1001 - 1008.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, C.-C.
Right arrow Articles by Waters, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, C.-C.
Right arrow Articles by Waters, D. J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS